Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients
- PMID: 7591260
- DOI: 10.1002/ijc.2910630410
Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients
Abstract
Wilms' tumor development, like most tumors, involves multiple genetic alterations affecting diverse genes. Only one of these has thus far been identified, the Wilms' tumor 1 (WT1) gene on 11p13, which functions as a tumor suppressor gene. We assessed the involvement of the WT1 gene constitutionally and somatically in 26 Wilms' tumor patients. Of these, the clinical data suggest a constitutional pre-disposition in 12 bilateral cases and 7 cases with early onset. We employed Southern blot analysis and PCR-based markers for analyses of somatic allelic losses in chromosome bands 11p13, 11p15 and 16q and screened for point mutations in exons 2-10 of the WT1 gene with denaturing gradient gel electrophoresis (DGGE). Of the 12 cases with multiple tumors, 1 exhibited a constitutional 11p13 deletion and a somatic stop mutation in exon 4 of the WT1 gene and 2 harbored constitutional mutations in the WT1 gene: a pre-mature stop codon in exon 6 in a boy with bilateral cryptorchidism and bilateral Wilms' tumors and an intragenic deletion in a girl with bilateral WT. Three additional bilateral tumors displayed WT1 rearrangements or allelic losses with 11p13 markers. Four of 7 patients with an early onset of unilateral tumor had losses of 11p13, though no WT1 mutations were detected. Two of the remaining cases that did not show any somatic or constitutional 11p13 alterations had Beckwith-Wiedemann syndrome, known to involve the 11p15 region.
Similar articles
-
Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.Am J Pathol. 1998 Sep;153(3):991-1000. doi: 10.1016/S0002-9440(10)65641-6. Am J Pathol. 1998. PMID: 9736048 Free PMC article.
-
Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.Br J Cancer. 1993 Jun;67(6):1259-61. doi: 10.1038/bjc.1993.235. Br J Cancer. 1993. PMID: 8390282 Free PMC article.
-
Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.Hum Mutat. 1994;3(3):212-22. doi: 10.1002/humu.1380030307. Hum Mutat. 1994. PMID: 8019557
-
The role of Wilms' tumor genes.J Med Invest. 1999 Aug;46(3-4):130-40. J Med Invest. 1999. PMID: 10687307 Review.
-
Molecular genetics of Wilms' tumour.J Paediatr Child Health. 1995 Oct;31(5):379-83. doi: 10.1111/j.1440-1754.1995.tb00841.x. J Paediatr Child Health. 1995. PMID: 8554853 Review.
Cited by
-
Software and database for the analysis of mutations in the human WT1 gene.Nucleic Acids Res. 1998 Jan 1;26(1):271-4. doi: 10.1093/nar/26.1.271. Nucleic Acids Res. 1998. PMID: 9399851 Free PMC article.
-
Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review.Cancer Sci. 2016 May;107(5):690-9. doi: 10.1111/cas.12910. Epub 2016 Mar 18. Cancer Sci. 2016. PMID: 26892980 Free PMC article. Review.
-
The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum.J Cancer Res Clin Oncol. 2019 Dec;145(12):3115-3123. doi: 10.1007/s00432-019-03038-3. Epub 2019 Oct 4. J Cancer Res Clin Oncol. 2019. PMID: 31583434 Free PMC article.
-
Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.Am J Hum Genet. 1998 Apr;62(4):824-33. doi: 10.1086/301806. Am J Hum Genet. 1998. PMID: 9529364 Free PMC article.
-
Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis.Exp Ther Med. 2019 Oct;18(4):2554-2564. doi: 10.3892/etm.2019.7870. Epub 2019 Aug 8. Exp Ther Med. 2019. PMID: 31555364 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical